REGENXBIO Inc. (RGNX) Financial Statements (2024 and earlier)

Company Profile

Business Address 9804 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:314,100565,200849,300522,500400,000470,600
Cash and cash equivalents34,52296,952345,209338,42669,51475,561
Short-term investments240,736267,690112,230137,314226,696244,200
Other undisclosed cash, cash equivalents, and short-term investments38,842200,558391,86146,760103,790150,839
Receivables24,79028,08232,43942,99938,1488,587
Prepaid expense14,52013,90018,75210,5056,4755,734
Other current assets20,4039,35210,1961,9534,1993,831
Other undisclosed current assets(38,842)(200,558)(391,861)(46,760)(103,790)(150,839)
Total current assets:334,971415,976518,826531,197345,032337,913
Noncurrent Assets
Operating lease, right-of-use asset60,48765,11660,90463,81510,078
Property, plant and equipment132,103141,685131,54756,46728,97328,702
Long-term investments and receivables39,572202,064394,16950,076107,940173,831
Long-term investments38,871200,560391,90746,809103,785150,819
Accounts and financing receivable, after allowance for credit loss7011,5042,2623,2674,15523,012
Restricted cash and investments2,0302,0302,0301,3301,3301,053
Other noncurrent assets4,8076,3976,4285,2794,5552,315
Total noncurrent assets:238,999417,292595,078176,967152,876205,901
TOTAL ASSETS:573,970833,2681,113,904708,164497,908543,814
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities37,47846,03043,30527,08817,54114,691
Taxes payable11,3253,135 726
Employee-related liabilities19,84913,15510,9039,484
Accounts payable22,78627,21311,38710,6226,4094,412
Accrued liabilities14,69218,81774417622969
Deferred revenue1481,8293,333449 
Debt     2,421 
Contract with customer, liability600
Other undisclosed current liabilities92,64682,57583,83453,91013,7146,885
Total current liabilities:130,272130,434130,47281,44733,67622,176
Noncurrent Liabilities
Long-term debt and lease obligation:   84,92970,1538,874 
Liabilities, other than long-term debt88,47197,6347454,3075,1616,936
Deferred revenue    3,7833,333
Contract with customer, liability3,333
Deferred rent credit      1,098
Other liabilities6,2498,8327455241,8282,505
Operating lease, liability82,22288,80284,92970,1538,874
Other undisclosed noncurrent liabilities43,48589,005133,460174,504 5,854
Total noncurrent liabilities:131,956186,639219,134248,96414,03512,790
Total liabilities:262,228317,073349,606330,41147,71134,966
Equity
Equity, attributable to parent311,742516,195764,298377,753450,197508,848
Common stock444444
Additional paid in capital1,021,214973,145928,095667,181627,810592,580
Accumulated other comprehensive income (loss)(4,429)(15,401)(2,569)(360)205(720)
Accumulated deficit(705,047)(441,553)(161,232)(289,072)(177,822)(83,016)
Total equity:311,742516,195764,298377,753450,197508,848
TOTAL LIABILITIES AND EQUITY:573,970833,2681,113,904708,164497,908543,814

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues90,242112,724470,347154,56735,233218,505
Cost of revenue(37,610)(54,545)(51,833)(43,689)(8,241)(9,682)
Cost of goods and services sold(37,213)(54,545)(51,833)(35,714)(8,241) 
Gross profit:52,63258,179418,514110,87826,992208,823
Operating expenses(320,760)(327,734)(260,770)(230,111)(176,000)(120,723)
Other operating income (expense), net     10(42)
Other undisclosed operating income 6,6792,236  42
Operating income (loss):(268,128)(262,876)159,980(119,233)(148,998)88,100
Nonoperating income (expense)4,482(17,529)(18,733)13,22351,51016,016
Investment income, nonoperating11,3195,3836,8259,72348,5597,070
Interest and debt expense(6,862)(23,254)(26,277)(771)  
Income (loss) from continuing operations before equity method investments, income taxes:(270,508)(303,659)114,970(106,781)(97,488)104,116
Other undisclosed income from continuing operations before income taxes6,86223,25426,277771  
Income (loss) from continuing operations before income taxes:(263,646)(280,405)141,247(106,010)(97,488)104,116
Income tax expense (benefit) 15284(13,407)(5,240)2,755(4,179)
Other undisclosed income from continuing operations      
Income (loss) from continuing operations:(263,494)(280,321)127,840(111,250)(94,733)99,937
Income (loss) before gain (loss) on sale of properties:127,840(111,250)(94,733)99,937
Other undisclosed net income      
Net income (loss) available to common stockholders, diluted:(263,494)(280,321)127,840(111,250)(94,733)99,937

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):(263,494)(280,321)127,840(111,250)(94,733)99,937
Other comprehensive income (loss)10,972(12,832)(2,209)(565)885(5)
Comprehensive income (loss), net of tax, attributable to parent:(252,522)(293,153)125,631(111,815)(93,848)99,932

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: